Altimmune (ALT) Interest Expenses (2010 - 2026)
Altimmune's Interest Expenses was $1.1 million in Q2 2026, up 315.5% from $264,000 a year earlier and up 2.7% from the prior quarter.
Powered by 
Analysis
Altimmune (ALT) Interest Expenses (2010 - 2026) Analysis & Trends
On a trailing twelve-month basis, Altimmune's Interest Expenses was $3.54 million through Jun 30, 2026; for FY2025, it was $1.64 million.
- Interest Expenses shows a five-year compound annual growth rate of 180.5% (FY2020 to FY2025).
- In earlier years, Interest Expenses was $9,000 in FY2024 (-74.3%), $35,000 in FY2023 (+337.5%), $8,000 in FY2022 (+60.0%) and $5,000 in FY2021 (-46.9%).
- The Q2 2026 figure marks the highest quarterly Interest Expenses since Q4 2010.
- Compared with a year earlier, Interest Expenses was higher in 1 of the last four quarters, with growth averaging 46.6%.
- The best year-over-year quarter for Interest Expenses over five years was Q1 2022 (growth of 416.7%); the worst was Q2 2023 (a decline of 96.9%).
- Per Business Quant data, ALT's Interest Expenses in the three quarters before Q2 2026 was $1.07 million (Q1 2026), $876,000 (Q4 2025) and $495,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 281.00 Mn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | - |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | -462.00 Mn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | -435.00 Mn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 673.00 Mn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 247.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | - |
| 10 | Altimmune | 577.59 Mn | 577.59 Mn | - | 1.10 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.10 Mn |
| Mar 31, 2026 | 1.07 Mn |
| Dec 31, 2025 | 876,000.00 |
| Sep 30, 2025 | 495,000.00 |
| Jun 30, 2025 | 264,000.00 |
| Mar 31, 2025 | 1,000.00 |
| Dec 31, 2024 | 1,000.00 |
| Sep 30, 2024 | 6,000.00 |
| Jun 30, 2024 | 1,000.00 |
| Mar 31, 2024 | 1,000.00 |
| Dec 31, 2023 | 2,000.00 |
| Sep 30, 2023 | 29,000.00 |
| Jun 30, 2023 | 2,000.00 |
| Mar 31, 2023 | 2,000.00 |
| Dec 31, 2022 | -183,000.00 |
| Sep 30, 2022 | 64,000.00 |
| Jun 30, 2022 | 65,000.00 |
| Mar 31, 2022 | 62,000.00 |
| Dec 31, 2021 | -62,000.00 |
| Sep 30, 2021 | 33,000.00 |
API Access
Altimmune Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-expenses&ticker=ALT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-expenses", "ticker": "ALT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-expenses&ticker=ALT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();